Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ning Lu

Showing results (801-810 of 819) with videos related to

Pageof 82
Sort By:
BMC Geriatrics|May 21, 2024
Preoperative chemoradiotherapy in older patients with rectal cancer guided by comprehensive geriatric assessment within a multidisciplinary team-a multicenter phase II trialWen-Yang Liu, Yuan Tang, Ning Li, et al.
Breast (Edinburgh, Scotland)|October 21, 2022
Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancerXu-Ran Zhao, Yu Tang, Hong-Fen Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2020
Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From ChinaShu-Lian Wang, Hui Fang, Chen Hu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2023
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation TherapyDan-Qiong Wang, Na Zhang, Li-Hua Dong, et al.
Cytokine|November 8, 2002
Analysis of novel disease-related genes in bronchial asthmaNoriko Yuyama, Donna E Davies, Mina Akaiwa, et al.
BMC Cancer|January 25, 2023
Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphomaYu-Ting Zhao, Si-Ye Chen, Xin Liu, et al.
JAMA Network Open|November 30, 2021
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical TrialNing Li, Yuan Zhu, Lu-Ying Liu, et al.
The Lancet. Haematology|May 5, 2025
Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trialXin-Yue Wang, Xi-Mei Zhang, Liang Wang, et al.
Radiation Oncology (London, England)|December 28, 2022
The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trialWen-Yang Liu, Jin-Ming Shi, Ning Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2020
AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer CellsMaria L Lotsberg, Katarzyna Wnuk-Lipinska, Stéphane Terry, et al.
Pageof 82

Showing results (801-810 of 819) with videos related to

Sort By:
Pageof 82
BMC Geriatrics|May 21, 2024
Preoperative chemoradiotherapy in older patients with rectal cancer guided by comprehensive geriatric assessment within a multidisciplinary team-a multicenter phase II trialWen-Yang Liu, Yuan Tang, Ning Li, et al.
Breast (Edinburgh, Scotland)|October 21, 2022
Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancerXu-Ran Zhao, Yu Tang, Hong-Fen Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2020
Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From ChinaShu-Lian Wang, Hui Fang, Chen Hu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2023
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation TherapyDan-Qiong Wang, Na Zhang, Li-Hua Dong, et al.
Cytokine|November 8, 2002
Analysis of novel disease-related genes in bronchial asthmaNoriko Yuyama, Donna E Davies, Mina Akaiwa, et al.
BMC Cancer|January 25, 2023
Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphomaYu-Ting Zhao, Si-Ye Chen, Xin Liu, et al.
JAMA Network Open|November 30, 2021
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical TrialNing Li, Yuan Zhu, Lu-Ying Liu, et al.
The Lancet. Haematology|May 5, 2025
Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trialXin-Yue Wang, Xi-Mei Zhang, Liang Wang, et al.
Radiation Oncology (London, England)|December 28, 2022
The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trialWen-Yang Liu, Jin-Ming Shi, Ning Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2020
AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer CellsMaria L Lotsberg, Katarzyna Wnuk-Lipinska, Stéphane Terry, et al.
Pageof 82